This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5–11 March 2023 and includes updates on COVID-19, group A streptococcal infection, influenza, diphtheria, measles, iatrogenic botulism, poliomyelitis, and autochthonous Dengue.
This report provides an overview of the main findings of the 2020–2021 harmonised AMR monitoring in Salmonella spp., Campylobacter jejuni and C. coli in humans and food-producing animals and relevant meat thereof.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 February - 5 March 2023 and includes updates on COVID-19, group A streptococcal infection, influenza and influenza A(H5N1) , Middle East respiratory syndrome coronavirus (MERS-CoV), Mpox, poliomyelitis, Marburg virus disease and the Earthquakes in Türkiye, Syria.
Immediate health needs following earthquakes in Türkiye and Syria are mostly related to trauma and the disruption of healthcare, however, infectious disease threats may be concerning in the following two to four weeks.
Increased numbers of shigellosis cases, mainly caused by Shigella sonnei, among travellers returning from Cabo Verde, have been reported in the EU/EEA, the United Kingdom (UK) and the United States (US) since September 2022.
An increased reporting of shigellosis cases, mainly caused by Shigella sonnei, among travellers returning from Cabo Verde has been ongoing in the European Union/European Economic Area (EU/EEA), the United Kingdom (UK), and the United States (US) since September 2022. This outbreak evolved rapidly during November and December 2022.
This issue of the Communicable Disease Threats Report (CDTR) covers the period 23-29 January 2023 and includes updates on COVID-19, diphtheriae, influenza, chikungunya, dengue and poliomyelitis.
For 2020, 28 countries reported 1 647 cases of hantavirus infection (0.4 cases per 100 000 population), mainly caused by Puumala virus (98%). During the period 2016–2020, the overall notification rate fluctuated between 0.4 and 1.0 cases per 100 00 population, with no obvious long-term trend.
This guidance document includes an updated summary of diagnostic PCR and serology together with detailed information on isolation, culture, identification and epidemiological typing of B. pertussis to help users choose the best methods within the local technical and financial provisions.
For 2021, 6 534 confirmed cases of STEC infection were reported by 30 EU/EEA countries (Table 1). Twenty-seven countries reported at least two confirmed cases, and three countries reported no cases. The EU/EEA notification rate was 2.2 cases per 100 000 population, representing a 37.5% increase compared with the previous year.